Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

F. Jänicke, Manfred Schmitt, L. Pache, +4

Breast Cancer Research and Treatment

Inhibitor Pai-1OncologyBreast OncologyMedicinePathology +8

Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up

Nadia Harbeck, Michael Untch, L. Pache, +1

British Journal of Cancer

Breast OncologyCancer DetectionBreast Cancer PatientsMedicineTumour Cell Detection +8

Radical surgical procedure improves survival time in patients with recurrent ovarian cancer

F. Jänicke, A. Search Holscher, Walther Kuhn, +4

Cancer

Urokinase (uPA) and PAI-1 Predict Survival in Advanced Ovarian Cancer Patients (FIGO III) after Radical Surgery and Platinum-Based Chemotherapy

W. Kühn, L. Pache, Barbara Schmalfeldt, +4

Gynecologic Oncology

UrologySurgical OncologyPai-1 Predict SurvivalMedicineFigo Iii +7

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

W. Kühn, Barbara Schmalfeldt, Ute Reuning, +10

British Journal of Cancer

Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer.

Christoph Thomssen, Manfred Schmitt, Lothar Goretzki, +5

PubMed

Breast OncologyOncologyCathepsin LBiochemistryCathepsins B +13

Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1.

F. Jänicke, L. Pache, Manfred Schmitt, +4

PubMed

Tumor BiologyBreast OncologyOncologyEndocrine-related CancerBreast Cancer Res +13

Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2.

Barbara Schmalfeldt, W. Kühn, Ute Reuning, +6

PubMed

UrologySurgical OncologyEndocrine-related CancerGenitourinary CancerMedicine +13

Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer

P. Dettmar, Nadia Harbeck, Christoph Thomssen, +8

British Journal of Cancer

Breast OncologyOncologyPrognostic ImpactProliferation-associated Factors Mib1Medicine +7

The influence of upper abdominal surgery on perioperative morbidity and mortality in patients with advanced ovarian cancer FIGO III and FIGO IV

W. Kühn, G. Florack, J. D. Roder, +8

International Journal of Gynecological Cancer

Surgical OncologyUpper Abdominal SurgeryPelvic Reconstructive SurgeryGastroenterologyGynecology +19